The MADS-box factor CeMEF2 is not essential for Caenorhebditis elegans myogenesis and development

Developmental Biology

Volumn 223, Issue 2, 2000, Pages 431-440

  Dichoso, Daryl ^a   Brodigan, Thomas ^a   Chwoe, Kyu Yeong ^b   Lee, Jin Sook ^b   Llacer, Reymond ^a   Park, Morgan ^a   Corsi, Ann K ^a   Kostas, Stephen A ^c   Fire, Andrew ^c   Ahnn, Joohong ^b   Krause, Michael ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

^c GEOPHYSICAL LABORATORY   (United States)

Author keywords

C. elegans; MADS box; MEF2; Myogenesis; SRF

Indexed keywords

SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR;

ALLELE; ARTICLE; CAENORHABDITIS ELEGANS; DNA BINDING; DNA SEQUENCE; DROSOPHILA MELANOGASTER; EMBRYO; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENETIC CONSERVATION; MUSCLE DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; MELANOGASTER; NEMATODA; VERTEBRATA;

EID: 0034661664     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.2000.9758     Document Type: Article

References (64)

1. Affolter M., Montagne J., Walldorf U., Groppe J., Kloter U., LaRosa M., Gehring W. J. The Drosophila SRF homolog is expressed in a subset of tracheal cells and maps within a genomic region required for tracheal development. Development. 120:1994;743-753.
2. Arsenian S., Weinhod B., Oelgeschlager M., Ruther U., Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17:1998;6289-6299.
3. Azpiazu N., Frasch M. tinman and bagpipe: Two homeo box genes that determine cell fates in the dorsal mesoderm of Drosophila. Genes Dev. 7:1993;1325-1340.
4. Baylies M. K., Bate M. twist: A myogenic switch in Drosophila. Science. 272:1996;1481-1484.
5. Bi W., Drake C. J., Schwarz J. J. The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev. Biol. 211:1999;255-267.
6. Black B. L., Ligon K. L., Zhang Y., Olson E. N. Cooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyte enhancer factor-2 (MEF2) family. J. Biol. Chem. 271:1996;26659-26663.
7. Black B. L., Olson E. N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF-2) proteins. Annu. Rev. Cell Dev. Biol. 14:1998;167-196.
8. Bodmer R. The gene tinman is required for specification of the heart and visceral muscles in Drosophila. Development. 118:1993;719-729.
9. Bour B. A., O'Brien M. A., Lockwood W. L., Goldstein E. S., Bodmer R., Taghert P. H., Abmayr S. M., Nguyen H. T. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9:1995;730-741.
10. Breibart R. E., Liang C. S., Smoot L. B., Laheru D. A., Mahdavi V., Nadal-Ginard B. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development. 118:1993;1095-1106.
11. Browning C. L., Culberson D. E., Aragon I. V., Fillmore R. A., Croissant J. D., Schwartz R. J., Zimmer W. E. The developmentally regulated expression of serum response factor plays a key role in the control of smooth muscle-specific genes. Dev. Biol. 194:1998;18-37.
12. Science. 282:1998;2012-2018.
13. Chalfie M., Tu Y., Euskirchen G., Ward W. W., Prasher D. C. Green fluorescent protein as a marker for gene expression. Science. 263:1994;802-805.
14. Chambers A., Logan M., Kotecha S., Towers N., Sparrow D., Mohun T. J. The RSRF/MEF2 protein SL1 regulates cardiac muscle-specific transcription of a myosin light-chain gene in Xenopus embryos. Genes Dev. 8:1994;1324-1334.
15. Chen L., Krause M. W., Draper B., Weintraub H., Fire A. Body-wall muscle formation in Caenorhabditis elegans embryos that lack the MyoD homolog hlh-1. Science. 256:1992;240-243.
16. Corsi A. K., Kostas S. A., Fire A., Krause M. Caenorhabditis elegans Twist plays an essential role in non-striated muscle development. Development. 127:2000;2041-2051.
17. Cripps R. M., Black B. L., Zhao B., Lien C. L., Schulz R. A., Olson E. N. The myogenic regulatory gene Mef2 is a direct target for transcriptional activation by Twist during Drosophila myogenesis. Genes Dev. 12:1998;422-434.
18. Dernburg A. F., McDonald K., Moulder G., Barstead R., Dresser M., Villeneuve A. M. Meiotic recombination in C. elegans initiates by a conserved mechanism and is dispensable for homologous chromosome synapsis. Cell. 94:1998;387-398.
19. Dodou E., Sparrow D. B., Mohun T., Treisman R. MEF2 proteins, including MEF2A, are expressed in both muscle and non-muscle cells. Nucleic Acids Res. 23:1995;4267-4274.
20. Fire A., Harrison S. W., Dixon D. K. A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans. Gene. 93:1990;189-198.
21. Fire A., Xu S. Q., Montgomery M. K., Kostas S. A., Driver S. E., Mello C. C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:1998;806-811.
22. Gajewski K., Kim Y., Lee Y. M., Olson E. N., Schulz R. A. D-mef2 is a target for Tinman activation during Drosophila heart development. EMBO J. 6:1997;515-522.
23. Gossett L. A., Kelvin D. J., Sternberg E. A., Olson E. N. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9:1989;5022-5033.
24. Granato M., Schnabel H., Schnabel R. Genesis of an organ: Molecular analysis of the pha-1 gene. Development. 120:1994;3005-3017.
25. Grayson J., Bassel-Duby R., Williams R. S. Collaborative interactions between MEF-2 and Sp1 in muscle-specific gene regulation. J. Cell. Biochem. 70:1998;366-375.
26. Guillemin K., Groppe J., Ducker K., Treisman R., Hafen E., Affolter M., Krasnow M. A. The pruned gene encodes the Drosophila serum response factor and regulates cytoplasmic outgrowth during terminal branching of the tracheal system. Development. 122:1996;1353-1362.
27. Harfe B. D., Gomes A. V., Kenyon C., Liu J., Krause M., Fire A. Analysis of a Caenorhabditis elegans Twist homolog identifies conserved and divergent aspects of mesodermal patterning. Genes Dev. 12:1998a;2623-2635.
28. Harfe B. D., Branda C. S., Krause M., Stern M. J., Fire A. MyoD and the specification of muscle and non-muscle fates in postembryonic development of the C. elegans mesoderm. Development. 125:1998b;2479-2488.
29. Krause M., Park M., Zhang J.-M., Yuan J., Harfe B., Xu S.-Q., Greenwald I., Cole M., Paterson B., Fire A. A C. elegans E/Daughterless bHLH protein marks neuronal but not striated muscle development. Development. 124:1997;2179-2189.
30. Krause M., Hirsh D. A trans-spliced leader sequence on actin mRNA in C. elegans. Cell. 49:1987;753-761.
31. Krause M. W. Regulation of transcription and translation. Epstein H. F., Shakes D. C. Caenorhabditis elegans: Modern Biological Analysis of an Organism. 1995;483-512 Academic Press, San Diego.
32. Landerholm T. E., Dong X.-R., Lu J., Narasimhaswamy S. B., Schwarz R. J., Majesky M. W. A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development. 126:1999;2053-2062.
33. Lilly B., Galewsky S., Firulli A. B., Schulz R. A., Olson E. N. D-MEF2: A MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis. Proc. Natl. Acad. Sci. USA. 91:1994;5662-5666.
34. Lilly B., Zhao B., Ranganayakulu G., Paterson B. M., Schulz R. A., Olson E. N. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science. 267:1995;688-693.
35. Lin Q., Lu J., Yanagisawa H., Webb R., Lyons G. E., Richardson J. A., Olson E. N. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development. 125:1998;4565-4574.
36. Mao Z., Bonni A., Xia F., Nadal-Vicns M., Greenberg M. E. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science. 286:1999;785-790.
37. McDermott J. C., Cardoso M. C., Yu Y. T., Andrés V., Leifer D., Kraine D., Lipton S. A., Nadal-Ginard B. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell. Biol. 13:1993;2564-2577.
38. Molkentin J. D., Black B. L., Martin J. F., Olson E. N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell. 83:1995;1125-1136.
39. Molkentin J. D., Firulli A. B., Black B. L., Martin J. F., Hustad C. M., Copeland N., Jenkins N., Lyons G., Olson E. N. MEF2B is a potent transactivator expressed in early myogenic lineages. Mol. Cell. Biol. 16:1996;3814-3824.
40. Naya F. J., Chuanzhen W., Richardson J. A., Overbeek P., Olson E. N. Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development. 126:1999;2045-2052.
41. Nguyen H. T., Xu X. Drosophila mef2 expression during mesoderm development is controlled by a complex array of cis-acting regulatory modules. Dev. Biol. 204:1998;550-566.
42. Norman C., Runsnick M., Pollock R., Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell. 55:1988;989-1003.
43. Nüsslein-Volhard C., Wieschaus E., Kluding H. Mutations affecting the pattern of the larval cuticle in Drosophila melanogaster. I. Zygotic loci on the second chromosome. Roux's Arch. Dev. Biol. 193:1984;267-282.
44. Okamato H., Thomson J. N. Monoclonal antibodies which distinguish certain classes of neuronal and supporting cells in the nervous tissue of the nematode Caenorhabditis elegans. J. Neurosci. 5:1985;643-653.
45. Pollock R., Treisman R. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 5:1991;2327-2341.
46. Ranganayakulu G., Zhao B., Dokidis A., Molkentin J. D., Olson E. N., Schulz R. A. A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev. Biol. 171:1995;169-181.
47. Rao S., Karray S., Gackstetter E. R., Koshland M. E. Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter. J. Biol. Chem. 273:1998;26123-26129.
48. Sartorelli V., Huang J., Hamamori Y., Kedes L. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1997;1010-1026.
49. Satyaraj E., Storb U. Mef2 proteins, required for muscle differentiation, bind an essential site in the Ig lambda enhancer. J. Immunol. 161:1998;4795-4802.
50. Schnabel H., Schnabel R. An organ-specific differentiation gene, pha-1, from Caenorhabditis elegans. Science. 250:1990;686-688.
51. Schulz R. A., Chromey C., Lu M. F., Zhao B., Olson E. N. Expression of the D-MEF2 transcription factor in the Drosophila brain suggests a role in neuronal cell differentiation. Oncogene. 12:1996;1827-1831.
52. Schwarz-Sommer Z., Huijser F., Nacken W., Saedler H., Sommer H. Genetic control of flower development by homeotic genes in Antirrhinum majus. Science. 250:1990;931-936.
53. Shore P., Sharrocks A. D. The MADS-box family of transcription factors. Eur. J. Biochem. 229:1995;1-13.
54. Simpson P. Maternal-zygotic gene interaction during formation of the dorsoventral pattern in Drosophila embryos. Genetics. 105:1983;615-632.
55. Spicer D. B., Rhee J., Cheung W. L., Lassar A. B. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein twist. Science. 272:1996;1476-1480.
56. Swanson B. J., Jack H. M., Lyons G. E. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. Mol. Immunol. 35:1998;445-458.
57. Taylor M. V., Beatty K. E., Hunter H. K., Baylies M. K. Drosophila MEF2 is regulated by twist and is expressed in both the primordia and differentiated cells of the embryonic somatic, visceral and heart musculature. Mech. Dev. 50:1995;29-41.
58. Treisman R. The SRE: A growth factor responsive transcriptional regulator. Semin. Cancer Biol. 1:1990;47-58.
59. Treisman R. Ternary complex factors: Growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4:1994;96-101.
60. Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., Blackwell T. K., Turner D., Rupp R., Hollenberg S., Zhuang Y., Lassar A. The myoD gene family: Nodal point during specification of the muscle cell lineage. Science. 251:1991;761-766.
61. 2+-induced release of the transcription factor MEF2. Science. 286:1999;790-793.
62. Yu Y. T., Breibart R. E., Smoot L. B., Lee Y., Mahdavi V., Nadal-Ginard B. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 6:1992;1783-1798.
63. Yun K., Wold B. Skeletal muscle determination and differentiation: Story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8:1996;877-889.
64. Zhang J.-M., Chen L., Krause M., Fire A., Paterson B. Evolutionary conservation of MyoD function and differential utilization of E proteins. Dev. Biol. 208:1999;465-472.